<html>
  <head>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
  </head>
  <body>
    <p align="left"> <a
href="https://everlast.mercola.com/r/?id=h35aa7c5f,21525dd3,216f2eda&et_cid=DM573732&et_rid=900365407"
        target="_blank" style="font-size:26px; font-family: verdana,
        arial, helvetica, sans-serif; font-weight:bold; color:#0e75cd;
        text-decoration:underline;"><strong>Initial COVID-19 Trials: The
          World's Deadliest Vaccine?</strong> </a> </p>
    <div
style="text-align:left;font-family:Helvetica,Arial,sans-serif;font-size:18px;
      color:#000000;line-height:135%; font-weight:normal;">1 in 5 phase
      1 volunteers suffered severe systemic side effects, suggesting
      vaccinating the global population would gravely injure at least
      1.5 billion people - and likely more, since only exceptionally
      healthy individuals were included.</div>
    <p align="left"> <a
href="https://everlast.mercola.com/r/?id=h35aa7c5f,21525dd3,216f2edb&et_cid=DM573732&et_rid=900365407"
        target="_blank" style="text-decoration: underline; color:
        #cc3333; font-family:Helvetica, Arial, sans-serif;
        font-size:17px; font-weight:normal; text-align:left;
        font-weight:bold">Read More >></a> </p>
    <h2><a moz-do-not-send="true"
href="https://articles.mercola.com/sites/articles/archive/2020/06/23/moderna-vaccine-coronavirus.aspx?cid_medium=etaf&cid=share">Warp
        Speed COVID-19 Vaccine Makes Big Pharma Crooks Rich</a><br>
    </h2>
    <div class="story-highlights">
      <h3 id="expanderHead" data-jsid="expanderHead">
        Story at-a-glance </h3>
      <div id="expanderContent" data-jsid="expanderContent">
        <ul>
          <li>
            <span id="bcr_rptStory_cslStory_0">Two Moderna executives
              cashed in $25 million when stock prices rose immediately
              following the announcement that its COVID-19 phase 1 trial
              showed promising results</span>
          </li>
          <li>
            <span id="bcr_rptStory_cslStory_1">Stock dropped within
              days, as critics pointed out the results were likely
              misrepresented and actually quite alarming</span>
          </li>
          <li>
            <span id="bcr_rptStory_cslStory_2">Twenty percent of
              Moderna’s phase 1 volunteers suffered severe systemic side
              effects. With a reaction rate of 20%, vaccinating the
              global population would gravely injure at least 1.5
              billion individuals, and likely more, since only
              exceptionally healthy volunteers were included</span>
          </li>
          <li>
            <span id="bcr_rptStory_cslStory_3">The most hazardous hurdle
              for Moderna’s COVID-19 vaccine lies ahead. Past attempts
              at creating coronavirus vaccines have failed, as both
              animal and human subjects would develop robust antibody
              responses but then become gravely ill when exposed to the
              wild virus. In some animal studies, all the animals died
              upon exposure to the wild virus</span>
          </li>
          <li>
            <span id="bcr_rptStory_cslStory_4">Coronaviruses have been
              shown to produce two different types of antibodies:
              neutralizing antibodies that fight the infection, and
              binding antibodies that cannot prevent viral infection.
              Binding antibodies can instead trigger “paradoxical immune
              enhancement,” causing severe illness and/or death when
              exposed to the wild virus</span></li>
        </ul>
        <p><a moz-do-not-send="true"
href="https://articles.mercola.com/sites/articles/archive/2020/06/23/moderna-vaccine-coronavirus.aspx?cid_medium=etaf&cid=share"><font
              size="+2">Read article  </font>  <font size="-1">https://articles.mercola.com/sites/articles/archive/2020/06/23/moderna-vaccine-coronavirus.aspx?cid_medium=etaf&cid=share</font></a></p>
      </div>
    </div>
  </body>
</html>